For Year 2025-26, Sai Life Sciences reports the following shareholding: Total Promoters at 34.7%, Mutual Fund at 27.57%, Insurance at 3.24%, Foreign Institutional Investors at 21.41%, Domestic Institutional Investors at 0.59%, and Retail at 12.49%. This breakdown provides a quick snapshot of ownership distribution for Sai Life Sciences in 2025-26.